
CVS Ordered to Pay Nearly $290M in Whistleblower Lawsuit
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay nearly $290 million in damages and penalties for overcharging Medicare for prescription drugs, citing fraudulent billing practices motivated by financial gain. CVS plans to appeal the decision, which stems from allegations that CVS Caremark inflated claims submitted to Medicare since 2010, damaging public trust and violating the False Claims Act.









